NCT06996028 LIFT & PEDALS on Balance and Mobility in Children With CP
| NCT ID | NCT06996028 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | CP |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-05-15 |
| Primary Completion | 2025-06-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-05-15 with a primary completion date of 2025-06-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Children with cerebral palsy (CP) have impaired balance due to poor postural control and coordination, increasing fall risk and limiting daily activities. This randomized controlled trial aims to compare the effects of Lower-Extremity Functional Training (LIFT) and Pediatric Endurance and Limb Strengthening (PEDALS) on balance and mobility in children with diplegic CP. A total of 22 children (ages 6-12) from Adil Special School, Sargodha, will be randomly assigned to two groups. One group will perform exercises targeting strength, coordination, gait, and balance; the other will perform pedaling exercises. Pre- and post-intervention assessments will include the 6-Minute Walk Test, GMFM-88, and Pediatric Balance Scale. Data will be analyzed using SPSS 23
Eligibility Criteria
Inclusion Criteria: * Gross Motor Function Classification System level of I to II * Ability to follow 2-step instructions and complete testing. * Age between 6 and 12 years. * Children with cerebral palsy Exclusion Criteria: * Cognitive delay preventing 2-step instructions * Visual problem preventing performance of interventions. * Caregivers unable to commit to duration of intervention. * If patient had unstable seizures. * If any change in medication was expected during the study.
Contact & Investigator
Aniqa Feroz, MS
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06996028 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 12 Years, studying CP. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06996028 currently recruiting?
Yes, NCT06996028 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06996028 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06996028 clinical trial?
NCT06996028 is sponsored by Riphah International University. The principal investigator is Aniqa Feroz, MS at Riphah International University. The trial plans to enroll 20 participants.